In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma

Journal of Neuro-Oncology

Volumn 91, Issue 2, 2009, Pages 127-139

  Maes, W ^a   Deroose, C ^b,c,d   Reumers, V ^a,b,c   Krylyshkina, O ^a,b   Gijsbers, R ^b,c   Baekelandt, V ^a,c   Ceuppens, J ^a   Debyser, Z ^b,c   Gool, Stefaan W ^a,d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^c KU Leuven   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Dendritic cells; Immunotherapy; In vivo bioluminescence; Malignant glioma; Stereomicroscopy; Validation

Indexed keywords

DENDRITIC CELL VACCINE; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; GLIOBLASTOMA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROGNOSIS; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR VOLUME;

ANIMALS; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CELL LINE, TUMOR; DENDRITIC CELLS; DIAGNOSTIC IMAGING; FEMALE; FLOW CYTOMETRY; GLIOMA; IMMUNOTHERAPY; LINEAR MODELS; LUCIFERASES; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 57449084713     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9691-5     Document Type: Article

References (63)

1. Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17(5):545-580. doi: 10.1101/gad.1047403
2. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH et al (2000) Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2(6):491-495. doi: 10.1038/sj.neo.7900121
3. Shah K, Tang Y, Breakefield X, Weissleder R (2003) Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 22(44):6865-6872. doi: 10.1038/sj.onc.1206748
4. Soling A, Theiss C, Jungmichel S, Rainov NG (2004) A dual function fusion protein of Herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma. Genet Vaccines Ther 2(1):7. doi: 10.1186/1479-0556-2-7
5. Weissleder R (2002) Scaling down imaging: Molecular mapping of cancer in mice. Nat Rev Cancer 2(1):11-18. doi: 10.1038/nrc701
6. Zhang Y, Bressler JP, Neal J, Lal B, Bhang HE, Laterra J et al (2007) ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging. Cancer Res 67(19):9389-9397. doi: 10.1158/0008-5472.CAN-07-0944
7. Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P et al (1997) Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66(4):523-531. doi: 10.1111/ j.1751-1097.1997.tb03184.x
8. Contag PR, Olomu IN, Stevenson DK, Contag CH (1998) Bioluminescent indicators in living mammals. Nat Med 4(2):245-247. doi: 10.1038/ nm0298-245
9. Contag CH, Jenkins D, Contag PR, Negrin RS (2000) Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2(1-2):41-52. doi: 10.1038/sj.neo.7900079
10. Cowey S, Szafran AA, Kappes J, Zinn KR, Siegal GP, Desmond RA et al (2007) Breast cancer metastasis to bone: Evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice. Clin Exp Metastasis 24(5):389-401. doi: 10.1007/ s10585-007-9076-8
11. Dickson PV, Hamner B, Ng CY, Hall MM, Zhou J, Hargrove PW et al (2007) In vivo bioluminescence imaging for early detection and monitoring of disease progression in a murine model of neuroblastoma. J Pediatr Surg 42(7):1172-1179. doi: 10.1016/j.jpedsurg.2007.02.027
12. Edinger M, Cao YA, Hornig YS, Jenkins DE, Verneris MR, Bachmann MH et al (2002) Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 38(16):2128-2136. doi: 10.1016/ S0959-8049(02)00410-0
13. Inoue Y, Izawa K, Tojo A, Nomura Y, Sekine R, Oyaizu N et al (2007) Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy. Exp Hematol 35(3):407-415. doi: 10.1016/j.exphem.2006.11.006
14. Jurczok A, Fornara P, Soling A (2008) Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: A new approach to optimize a syngeneic, orthotopic, murine bladder cancer model. BJU Int 101(1):120-124
15. Liao CP, Zhong C, Saribekyan G, Bading J, Park R, Conti PS et al (2007) Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Res 67(15):7525-7533. doi: 10.1158/0008-5472.CAN-07-0668
16. Murray LJ, Abrams TJ, Long KR, Ngai TJ, Olson LM, Hong W et al (2003) SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model. Clin Exp Metastasis 20(8):757-766. doi: 10.1023/B:CLIN.0000006873.65590.68
17. Notting IC, Buijs JT, Que I, Mintardjo RE, van der HG, Karperien M et al (2005) Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis. Invest Ophthalmol Vis Sci 46(5):1581-1587. doi: 10.1167/iovs.04-0245
18. Ragel BT, Elam IL, Gillespie DL, Flynn JR, Kelly DA, Mabey D et al (2008) A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. J Neurosurg 108(2):304-310. doi: 10.3171/JNS/2008/108/2/0304
19. Sarraf-Yazdi S, Mi J, Dewhirst MW, Clary BM (2004) Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice. J Surg Res 120(2):249-255. doi: 10.1016/j.jss.2004.03.013
20. Tannehill-Gregg SH, Levine AL, Nadella MV, Iguchi H, Rosol TJ (2006) The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice. Clin Exp Metastasis 23(1):19-31. doi: 10.1007/s10585-006-9008-z
21. Wang Y, Sun Z, Peng J, Zhan L (2007) Bioluminescent imaging of hepatocellular carcinoma in live mice. Biotechnol Lett 29(11):1665-1670. doi: 10.1007/s10529-007-9452-0
22. Grauer OM, Nierkens S, Bennink E, Toonen LW, Boon L, Wesseling P et al (2007) CD4+FoxP3+regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo. Int J Cancer 121(1):95-105. doi: 10.1002/ijc.22607
23. Newcomb EW, Demaria S, Lukyanov Y, Shao Y, Schnee T, Kawashima N et al (2006) The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas. Clin Cancer Res 12(15):4730-4737. doi: 10.1158/ 1078-0432.CCR-06-0593
24. Spagnolo A, Glick RP, Lin H, Cohen EP, Feinstein DL, Lichtor T (2007) Prolonged survival of mice with established intracerebral glioma receiving combined treatment with peroxisome proliferator-activated receptor-gamma thiazolidinedione agonists and interleukin-2-secreting syngeneic/allogeneic fibroblasts. J Neurosurg 106(2):299-305. doi: 10.3171/jns.2007.106.2.299
25. Szatmari T, Lumniczky K, Desaknai S, Trajcevski S, Hidvegi EJ, Hamada H et al (2006) Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci 97(6):546-553. doi: 10.1111/j.1349-7006.2006.00208.x
26. Contag CH, Ross BD (2002) It's not just about anatomy: In vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging 16(4):378-387. doi: 10.1002/jmri.10178
27. Deroose CM, De A, Loening AM, Chow PL, Ray P, Chatziioannou AF et al (2007) Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging. J Nucl Med 48(2):295-303
28. Hollingshead MG, Bonomi CA, Borgel SD, Carter JP, Shoemaker R, Melillo G et al (2004) A potential role for imaging technology in anticancer efficacy evaluations. Eur J Cancer 40(6):890-898. doi: 10.1016/ j.ejca.2003.12.018
29. Paroo Z, Bollinger RA, Braasch DA, Richer E, Corey DR, Antich PP et al (2004) Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging 3(2):117-124. doi: 10.1162/1535350041464865
30. Soling A, Rainov NG (2003) Bioluminescence imaging in vivo - application to cancer research. Expert Opin Biol Ther 3(7):1163-1172
31. Szentirmai O, Baker CH, Lin N, Szucs S, Takahashi M, Kiryu S et al (2006) Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: Correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect. Neurosurgery 58(2):365-372. doi: 10.1227/01.NEU.0000195114.24819.4F
32. Hsu AR, Cai W, Veeravagu A, Mohamedali KA, Chen K, Kim S et al (2007) Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. J Nucl Med 48(3):445-454
33. Kemper EM, Leenders W, Kusters B, Lyons S, Buckle T, Heerschap A et al (2006) Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies. Eur J Cancer 42(18):3294-3303. doi: 10.1016/j.ejca.2006.07.013
34. Ohlfest JR, Demorest ZL, Motooka Y, Vengco I, Oh S, Chen E et al (2005) Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma. Mol Ther 12(5):778-788. doi: 10.1016/j.ymthe.2005.07.689
35. Deroose CM, Reumers V, Gijsbers R, Bormans G, Debyser Z, Mortelmans L et al (2006) Noninvasive monitoring of long-term lentiviral vector-mediated gene expression in rodent brain with bioluminescence imaging. Mol Ther 14(3):423-431. doi: 10.1016/j.ymthe.2006.05.007
36. Mustafa M, Diener P, Sun JB, Link H, Olsson T (1993) Immunopharmacologic modulation of experimental allergic encephalomyelitis: Low-dose cyclosporin-A treatment causes disease relapse and increased systemic T and B cell-mediated myelin-directed autoimmunity. Scand J Immunol 38:499-507. doi: 10.1111/j.1365-3083.1993.tb03232.x
37. Saito R, Mizuno M, Nakahara N, Tsuno T, Kumabe T, Yoshimoto T et al (2004) Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-beta gene therapy for malignant glioma in an experimental mouse intracranial glioma. Int J Cancer 111:777-782. doi: 10.1002/ijc.20331
38. Schmitz C, Hof PR (2005) Design-based stereology in neuroscience. Neuroscience 130(4):813-831. doi: 10.1016/j.neuroscience.2004.08.050
39. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S et al (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176(6):1693-1702. doi: 10.1084/jem.176.6.1693
40. Lutz MB, Kukutsch N, Ogilvie ALJ, Rossner S, Koch F, Romani N et al (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223:77-92. doi: 10.1016/S0022-1759(98)00204-X
41. Van Meirvenne S, Straetmen L, Heirman C, Dullaers M, De Greef C, Van Tendeloo VF et al (2002) Efficient genetic modification of murine dendritic cells by electroporation with mRNA. Cancer Gene Ther 9:787. doi: 10.1038/sj.cgt.7700499
42. Jenkins DE, Oei Y, Hornig YS, Yu SF, Dusich J, Purchio T et al (2003) Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20(8):733-744. doi: 10.1023/B:CLIN.0000006815.49932.98
43. Craft N, Bruhn KW, Nguyen BD, Prins R, Liau LM, Collisson EA et al (2005) Bioluminescent imaging of melanoma in live mice. J Invest Dermatol 125(1):159-165. doi: 10.1111/j.0022-202X.2005.23759.x
44. Fomchenko EI, Holland EC (2006) Mouse models of brain tumors and their applications in preclinical trials. Clin Cancer Res 12(18):5288-5297. doi: 10.1158/1078-0432.CCR-06-0438
45. Blouw B, Song H, Tihan T, Bosze J, Ferrara N, Gerber HP et al (2003) The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 4(2):133-146. doi: 10.1016/S1535-6108(03)00194-6
46. Ciesielski MJ, Apfel L, Barone TA, Castro CA, Weiss TC, Fenstermaker RA (2006) Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas. Cancer Immunol Immunother 55(12):1491-1503. doi: 10.1007/s00262-006-0138-6
47. Eyupoglu IY, Hahnen E, Heckel A, Siebzehnrubl FA, Buslei R, Fahlbusch R et al (2005) Malignant glioma-induced neuronal cell death in an organotypic glioma invasion model. Technical note. J Neurosurg 102(4):738-744
48. O I, Blaszczyk-Thurin M, Shen CT, Ertl HC (2003) A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma. Cancer Gene Ther 10(9):678-688. doi: 10.1038/sj.cgt.7700620
49. Manley GT, Binder DK, Papadopoulos MC, Verkman AS (2004) New insights into water transport and edema in the central nervous system from phenotype analysis of aquaporin-4 null mice. Neuroscience 129(4):983-991. doi: 10.1016/j.neuroscience.2004.06.088
50. El Andaloussi A, Han Y, Lesniak MS (2006) Prolongation of survival following depletion of CD4+CD25+regulatory T cells in mice with experimental brain tumors. J Neurosurg 105(3):430-437. doi: 10.3171/ jns.2006.105.3.430
51. El Andaloussi A, Sonabend AM, Han Y, Lesniak MS (2006) Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors. Glia 54(6):526-535. doi: 10.1002/ glia.20401
52. Fecci PE, Sweeney AE, Grossi PM, Nair SK, Learn CA, Mitchell DA et al (2006) Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells. Clin Cancer Res 12(14 Pt 1):4294-4305. doi: 10.1158/ 1078-0432.CCR-06-0053
53. Ni HT, Spellman SR, Jean WC, Hall WA, Low WC (2001) Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas. J Neurooncol 51(1):1-9. doi: 10.1023/ A:1006452726391
54. Pellegatta S, Poliani PL, Corno D, Grisoli M, Cusimano M, Ubiali F et al (2006) Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice. Neurol Res 28(5):527-531. doi: 10.1179/ 016164106X116809
55. Scheel B, Aulwurm S, Probst J, Stitz L, Hoerr I, Rammensee HG et al (2006) Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA. Eur J Immunol 36(10):2807-2816. doi: 10.1002/eji.200635910
56. Tsugawa T, Kuwashima N, Sato H, Fellows-Mayle WK, Dusak JE, Okada K et al (2004) Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response. Gene Ther 11(21):1551-1558. doi: 10.1038/sj.gt.3302300
57. Yamanaka R, Xanthopoulos KG (2005) Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18. DNA Cell Biol 24(5):317-324. doi: 10.1089/dna.2005.24.317
58. Prins RM, Shu CJ, Radu CG, Vo DD, Khan-Farooqi H, Soto H, et al (2008) Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain. Cancer Immunol Immunother; Epub ahead of print
59. Hakamata Y, Murakami T, Kobayashi E (2006) "Firefly rats" as an organ/cellular source for long-term in vivo bioluminescent imaging. Transplantation 81(8):1179-1184. doi: 10.1097/01.tp.0000203137.06587.4a
60. Shah K, Hingtgen S, Kasmieh R, Figueiredo JL, Garcia-Garcia E, Martinez-Serrano A et al (2008) Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model. J Neurosci 28(17):4406-4413. doi: 10.1523/ JNEUROSCI.0296-08.2008
61. Hsu AR, Hou LC, Veeravagu A, Greve JM, Vogel H, Tse V et al (2006) In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model. Mol Imaging Biol 8(6):315-323. doi: 10.1007/s11307-006-0059-y
62. Breart B, Lemaitre F, Celli S, Bousso P (2008) Two-photon imaging of intratumoral CD8+T cell cytotoxic activity during adoptive T cell therapy in mice. J Clin Invest 118(4):1390-1397. doi: 10.1172/JCI34388
63. Greschus S, Kiessling F, Lichy MP, Moll J, Mueller MM, Savai R et al (2005) Potential applications of flat-panel volumetric CT in morphologic and functional small animal imaging. Neoplasia 7(8):730-740. doi: 10.1593/neo.05160